Clinical Trials Directory

Trials / Unknown

UnknownNCT00345280

Ocular Surface Changes in Patients With Cystic Fibrosis

Chosen Parameters of the Immune Response in the Origin of Ocular Changes in Patients With Cystic Fibrosis

Status
Unknown
Phase
Study type
Observational
Enrollment
26 (estimated)
Sponsor
University of Bialystok · Other Government
Sex
All
Age
3 Years – 25 Years
Healthy volunteers
Accepted

Summary

Cystic fibrosis(CF) is an inherited disease affecting children, adolescents and young adults with dysfunction of secretory glands.It is caused by mutations in the protein-coding gene which function as the cystic fibrosis transmembrane regulator (CFTR), responsible for the secretion of chloride ions in epithelial cells, adenocytes, sweat gland cells, pancreatic ducts,alimentary and respiratory tracts and eye. Assessment of the relationship between the inflammatory processes and apoptosis in the eye in the course of cystic fibrosis will allow determination of immunological exponents which may facilitate diagnosis.

Detailed description

The aim: To assess the role of chosen parameters of immunological response in the induction of ocular changes in cystic fibrosis patients, particularly chosen chemokine concentrations in the tear fluid and analysis of chosen apoptotic markers expression on conjunctival epithelial cells.

Conditions

Interventions

TypeNameDescription
PROCEDUREimpression cytology, obtain the tear fluidVitamin A

Timeline

Start date
2006-08-01
Completion
2008-09-01
First posted
2006-06-28
Last updated
2008-06-17

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT00345280. Inclusion in this directory is not an endorsement.